pioneer 2 semaglutide Safety and efficacy of oral versus dulaglutide in Japanese patients with type diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial Efficacy, safety and cardiovascular outcomes

FIGURE 4 Glucagon-like peptide-1 receptor agonist-related other neoplasms Supplementary Figure S6 and Figure 5 demonstrate that the lower limit of PRR for GLP-1RA-associated bile duct cancer was greater than 1 in the first three models but less than 1 in model 4 (PRR 1.42, 95% CI 0.962.10, p = 0.03) and model 5 (PRR 1.39, 95% CI 0.952.03, p = 0.09)

CHI Last Week:29 Record: 15-46 OffRtg: 108.7 (30) DefRtg: 116.7 (24) NetRtg: -8.0 (27) Pace: 101.9 (8) The Pacers are holding onto last place in the Eastern Conference, having lost their last six games

(36464132) Antibody to insulin receptor (although this typically presents with extreme insulin resistance, causing diabetes)

Semaglutide isnt a stimulant

Source: Based on Finnigan et al